Boyle James T. Jr.
EVP,CEO of LabCorp Diagnostics at LH
- Sold, on record
- $24.2M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Mar 31, 2016
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LHLABCORP HOLDINGS INC.EVP,CEO of LabCorp Diagnostics
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale LHUnusualJun 9 2014
Sold 38,600 shares at $103.00 ($4M)
Boyle James T. Jr., EVP, Chief Operating Officer
Sold 59.9% of holdings ($6.6M position)25,821 shares left9.4x usual sizeFiling
- 2 Form 4 sale LHPlan not statedFeb 13 +249 days
Sold 6,597 shares at $116.68 ($770k)
Boyle James T. Jr., EVP, Chief Operating Officer
Sold 20.3% of holdings ($3.8M position)25,821 shares left0.5x usual sizeFiling
- 3 Form 4 sale LHPlan not statedMar 3 +18 days
Sold 1,237 shares at $123.70 ($153k)
Boyle James T. Jr., EVP, Chief Operating Officer
Sold 5% of holdings ($3.1M position)23,454 shares left0.2x usual sizeFiling
- 4 Form 4 sale LHPlan not statedApr 23 +51 days
Sold 1,394 shares at $126.56 ($176k)
Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics
Sold 5.6% of holdings ($3.1M position)23,454 shares left0.3x usual sizeFiling
- 5 Form 4 sale LHPlan not statedFeb 12 +295 days
Sold 2,712 shares at $101.67 ($276k)
Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics
Sold 10.4% of holdings ($2.7M position)23,454 shares left1.1x usual sizeFiling
- 6 Form 4 sale LHPlan not statedFeb 16 +4 days
Sold 4,055 shares at $103.02 ($418k)
Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics
Sold 14.7% of holdings ($2.8M position)23,454 shares left1.6x usual sizeFiling
- 7 Form 4 sale LHPlan not statedMar 14 +27 days
Sold 1,543 shares at $115.32 ($178k)
Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics
Sold 6.2% of holdings ($2.9M position)23,454 shares left0.6x usual sizeFiling
- 8 Form 4 sale LHUnusualMar 31 +17 days
Sold 18,132 shares at $116.81 ($2.1M)
Boyle James T. Jr., EVP,CEO of LabCorp Diagnostics
Sold 43.6% of holdings ($4.9M position)23,454 shares left6.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (15)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2016 | LH | EVP,CEO of LabCorp Diagnostics | Form 4 sale | 18,132 | $2.1M | 43.6% | Unusual | SEC |
| Mar 14, 2016 | LH | EVP,CEO of LabCorp Diagnostics | Form 4 sale | 1,543 | $178k | 6.2% | Plan not stated | SEC |
| Feb 16, 2016 | LH | EVP,CEO of LabCorp Diagnostics | Form 4 sale | 4,055 | $418k | 14.7% | Plan not stated | SEC |
| Feb 12, 2016 | LH | EVP,CEO of LabCorp Diagnostics | Form 4 sale | 2,712 | $276k | 10.4% | Plan not stated | SEC |
| Apr 23, 2015 | LH | EVP,CEO of LabCorp Diagnostics | Form 4 sale | 1,394 | $176k | 5.6% | Plan not stated | SEC |
| Mar 3, 2015 | LH | EVP, Chief Operating Officer | Form 4 sale | 1,237 | $153k | 5.0% | Plan not stated | SEC |
| Feb 13, 2015 | LH | EVP, Chief Operating Officer | Form 4 sale | 6,597 | $770k | 20.3% | Plan not stated | SEC |
| Jun 9, 2014 | LH | EVP, Chief Operating Officer | Form 4 sale | 38,600 | $4M | 59.9% | Unusual | SEC |
| Mar 28, 2014 | LH | EVP, Chief Operating Officer | Form 4 sale | 2,521 | $248k | 8.9% | Plan not stated | SEC |
| Mar 3, 2014 | LH | EVP, Chief Operating Officer | Form 4 sale | 1,582 | $147k | 5.8% | Plan not stated | SEC |
| Feb 13, 2014 | LH | EVP, Chief Operating Officer | Form 4 sale | 4,123 | $372k | 12.8% | Plan not stated | SEC |
| Feb 11, 2014 | LH | EVP, Chief Operating Officer | Form 4 sale | 1,204 | $110k | 4.1% | Plan not stated | SEC |
| Oct 17, 2013 | LH | EVP, Chief Operating Officer | Form 4 sale | 24,400 | $2.5M | 44.9% | Unusual | SEC |
| Jun 7, 2013 | LH | EVP, Chief Operating Officer | Form 4 sale | 63,100 | $6.3M | 67.8% | Unusual | SEC |
| May 10, 2013 | LH | EVP, Chief Operating Officer | Form 4 sale | 68,908 | $6.5M | 69.7% | Unusual | SEC |